baber/WOPTO huggingface dataset:
Patent GE-P20043315-B (GE)
Title: Non-Peptide GnRH Agents, Methods For Their Preparation and Use Thereof
Inventor: ANDERSON MARK BRIAN
IPC: C07D471/04
Filed: 1999-08-20
Abstract: 1. Technical Result Increase in efficiency of biodistribution in an organism. 2. Essence A composition of the formula or its pharmaceutically acceptable salts, multimers: prodrugs or active metabolites and compound of the formula (1) (wherein R1 - R9, X and het have the value indicated in the description), pharmaceutical composition containing the same and use thereof to obtain the medicament for regulation of gonadotropin secretion with mammalians. 3. Field of Application Medicine.
Patent GE-P19991822-B (GE)
Title: Means for Potentiation of Lactation
Inventor: MUMLADZE NADEZHDA
IPC: A61K36/00
Filed: 1999-01-13
Abstract: Widening of medicinal means assortment, increase in treatment efficiency and reduction in treatment terms.          2. Essence A means comprises an extract of roots and stems of Astragalus Caucasicus. 3. Field of Application Medicine, obstetric-gynecology.
Patent GE-P20032974-B (GE)
Title: Crystalline Forms of 1S-[1alpha (2s*,3r*), 9alpha]-6, 10-Dioxo-N- (2-Ethoxy-5 -Oxo-Tetrahydro-3 -Furanyl) -9-[[(1-Isoquinolyl) Carbonyl]-Amino] Octahydro-6H-Piridazino[1,2-A][1,2] Diazepin-1- Carboxamide. Method for Their Production and Pharmaceutical Compositions Containing Them for Treatment of Diseases Caused by Activity of 1Beta Interleukine Conversion Enzyme
Inventor: ROGNON VALERIE
IPC: A61K38/06
Filed: 1999-04-07
Abstract: 1. Technical Result Increase in effectiveness of treatment of diseases caused by activity of 1beta interleukine conversion enzyme.          2. Essence The crystalline forms A and B have the characteristics indicated in the description;  crystalline forms A and B are obtained by solving amorphous 1S-[1alpha(2S*, 3R*), 9alpha]-6, 10-dioxo-N- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl)-9-[[( 1-isoquinolyl) carbonyl]-amino] octahydro-6H –piridazino [1,2-a][1,2]diazepin-1 -carboxamide, in the acceptable organic solvent or the mixture thereof, in particular in ether or in spirit or in the mixture thereof with the following crystallization; the mentioned crystalline forms A and B are used to prepare the medicinal means for inhibiting activity of 1beta interleukine conversion enzyme.         3. Field of Application Medicine.                        Tables: 1
Patent GE-P20043247-B (GE)
Title: Direct Voltage Power Supply Source
Inventor: KIPSHIDZE MALKHAZ
IPC: H05B41/00
Filed: 2001-09-17
Abstract: 1. Technical Result Simplification of electric circuit, reduce of mass and overall size, reduce of cost.         2. Essence A device comprises in parallel switched an input rectifier 1, a diode condenser unit 2 and a compensating unit 8, to which a loading 12 is switched. The diode condenser unit comprises condensers 3 and 4, diode 6 switched between them in series and diodes 5 and 7 switched by one in parallel to circuits arranged from diode 6 and each of these condensers. There are two circuits of the compensating unit: in accordance to the first one, the unit 8 comprises in series switched a condenser and a diode, parallel to which an electronic switch is connected, and in accordance to another one – in series switched a condenser and a diode and in parallel switched to this condenser a high-frequency transformer, to the secondary circuit of which a diode is additionally switched.         3. Field of Application Power electronics.
Patent GE-P20043402-B (GE)
Title: Body Massage Device
Inventor: SIBASHVILI GEORGE
IPC: A61H15/00
Filed: 2003-07-25
Abstract: 1. Technical Result Increase in efficiency of therapeutic effect. 2. Essence A body massage device comprises a roller 1 with relief part 2, the length of which is equal to the average width of a foot, the diameter of the roller being 2-5 cm; the roller is placed into bushes 3 rotatably. The bushes are fixed on supports 5 by stands 4 in such a way that on the support there are free ends 6, the length of one of which is greater than that of another one. The support has the means for fixing it on the floor. 3. Field of Application Medicine and may be used in medicinal, prophylactic, sport and sanitary institutions and at home as well.
Patent GE-P20125529-B (GE)
Title: Internal combustion engine
Inventor: KHUTSISHVILI SHOTA
IPC: F02B71/00
Filed: 2007-10-19
Abstract: An internal combustion engine comprises cylinders 1 and 2 and a piston 9. At the opposite ends of each cylinder, a combustion chamber 3 provided with a spark plug 4 and a carburetor 5 is placed. The piston has an operating surface at both sides and is capable of performing free motion in the space between the chambers. In addition, an exhaust gas discharge valve of each combustion chamber is connected with a turbine through a manifold and each sparking plug and carburetor are discretely operable.
Patent GE-P20125713-B (GE)
Title: Method of virtual museum creation
Inventor: NATSVLISHVILI GIA
IPC: G09F19/00
Filed: 2009-11-09
Abstract: A method provides for museum pieces reco¬rding by three-dimensional scanning method, corre¬spo¬nding database forming and provision by templet model visualization. At that, technological cycle from scanning to visualization is implemented by data vector. In addition, three-dimensional vector realiza¬tion of the museum pieces location is implemented.
Patent GE-P20156304-B (GE)
Title: Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
Inventor: CHUNG YOUNG SIK
IPC: A61P9/00
Filed: 2011-12-07
Abstract: There is represented formulation containing lercanidipine hydrochloride and valsartan; at that those substances are included therein separately.
Patent DK-149102-C (DK)
Inventor: STORNI ANGELO
IPC: C07C215/38
Filed: 1980-02-01
Granted: 1986-06-09
Abstract: For all designated states : BE, CH, DE, FR, GB, IT, LU, NL, SE 1. S-(+)-alpha-[methylamino)methyl]-9-10-ethano anthracene-9(10H)-ethanol of the formula I  see diagramm : EP0014434,P11,F1  or an acid addition salt thereof. For the contracting state : AT 1. A process for the production of S-(+)-alpha-([methylamino)methyl]-9-10-ethano anthracene-9(10H)-ethanol of the formula I ad indicated in claim 1, or of an acid addition salt thereof, which process comprises a) resolving the racemic alpha-[(methylamino)-methyl]-9-10-ethanoanthracene- 9(10H)-ethanol and isolating S-(+)-alpha-[(methylamino)-methyl]-9-10-ethano anthracene-9(10H)-ethanol, if desired in the form of an acid addition salt, or b) reacting a compound of the formula II  see diagramm : EP0014434,P12,F1  with a compound of the formula III X2 -CH3 wherein one of X1  and X2  is the amino group and the other is a reactive esterified hydroxyl group, and Y1 is a free hydroxyl group, and X1 together with Y1  can also be an epoxy group, and A is the 9,10-ethanoanthracen-9(10H)-yl radical, or c) in a compound of the formula IV  see diagramm : EP0014434,P12,F2  in which at least one of Z1  and Z2  is a removable radical and the other may be hydrogen, or Z1  and Z2 together are a divalent removable radical, and A is the 9,10-ethanoanthracen-9(10H)-yl radical, removing Z1 and/or Z2 , d) reducing a compound which differs from the compound of the formula I only in that, in said compound, a carbon atom adjacent to the nitrogen atom is attached to this latter through a double bond or is substituted by a hydroxyl group or an oxo radical, optionally together with lower alkoxy, or e) adding ethylene to S-alpha-[(methylamino)-methyl]-9(10H)-anthracene, or hydrolyzing the intermediate obtained, and, if desired, converting the resultant S-(+)-alpha-[(methylamino)methyl]-9,10-ethanoanthracen- e-9(10H)-ethanol into an acid addition salt and/or liberating the base from a resultant acid addition salt.
Patent DK-157861-C (DK)
Inventor: KARJALAINEN ARTO JOHANNES
IPC: C07D263/32
Filed: 1981-02-11
Granted: 1990-07-30
Abstract: The invention provides compounds of the formula:wherein each of R<sub>1</sub>, R<sub>2</sub> and R<sub>3</sub>, which can be the same or different is hydrogen, chloro, bromo, fluoro, methyl, ethyl, methoxv, amino, hydroxy or nitro; R<sub>4</sub> is hydrogen or alkyl of 1 to 7 carbon atoms; X is(R<sub>5</sub> is hydrogen or hydroxy) and n is 1-4; and their non-toxic pharmaceutically acceptable acid addition salts. These compounds exhibitvaluable pharmacological activity and are useful in the treatment of mammals, especially as anti- hypertensive agents. Furthermore, some of the compounds have proved to possess diuretic, ß-blocking activity and/or antithrombotic activity. The compounds may be made by a variety of methods and may be incorporated in pharmaceutical compositions also comprising a compatible pharmaceutically acceptable carrier.
Patent CA-1282321-C (CA)
Title: Emulsifiable concentrates containing azoles
Inventor: LIGTVOET THEO F M C
IPC: A01N25/04
Filed: 1985-02-28
Granted: 1991-04-02
Abstract: ABSTRACT          EMULSIFIABLE CONCENTRATES CONTAINING AZOLES.    Formulations being compatible with aqueous and non-aqueous mediums, said formulations containing an azole, a solvent and an emulsifying agent.
Patent CA-1297410-C (CA)
Title: Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
Inventor: MCNAMARA THOMAS F
IPC: A23K20/195
Filed: 1986-01-21
Granted: 1992-03-17
Abstract: ABSTRACT OF THE DISCLOSURE      Tetracyclines  having  substantially  no  effective antibiotic or antibacterial activity  and  possessing anti-collagen-destructive  enzyme activity or anti-collagenase  activity  and  compositions  containing the same  have  been found  useful  as  anti-collagenolytic agents.   Such tetracyclines and compositions containing the  same  are. useful  in  the treatment  of periodontal diseases,  corneal  ulcers,  bone deficiency  disorders, rheumatoid arthritis diseases characterized by excessive collagen  destruction.     A  special  aspect  of  this invention   involves   the   incorporation   of   such tetracyclines in animal feed compositions for improved animal nutrition, such as may be evidenced by increased weight gain.
Patent CA-1280031-C (CA)
Title: Aromatics recovery
Inventor: GHODSIZADEH YOUSEF
IPC: A23L27/10
Filed: 1986-04-10
Granted: 1991-02-12
Abstract: Abstract A process for recovering volatile aroma components from aroma-bearing vegetable materials such as roast and ground coffee. A carrier gas is passed through the vegetable material to strip aromas therefrom, and the resulting aroma-laden gas is contacted with a cryogenic liquid such as liquid nitrogen to condense the aromas from the gas. The carrier gas has a boiling point equal to or lower than that of the cryogenic liquid. Because the efficacy of the condensation step is substantially independent of the gas flow rate, the optimum gas flow rate for effective stripping may be used without loss of aromas at the condensation step.
Patent CA-1277821-C (CA)
Title: Refractory plate and method for reinforcing
Inventor: SCHURMEIER GUSTAVE B
IPC: B22D41/30
Filed: 1986-08-18
Granted: 1990-12-18
Abstract: Abstract Refractory Plate and Method for Reinforcing A refractory member adapted for use in a casting vessel valve is disclosed including a refractory plate, a wire helically wound around the periphery of the plate, and means rigidly interconnecting the helical windings to one another.  A method is also disclosed for reinforcing a valve plate, including the steps of heat-ing a metal wire into a malleable state, securing one end of the wire with respect to the plate, helically winding the heated wire about the plate with the wind-ings substantially abutting one another, and welding together each wire winding with the abutting windings at at least one spot.  An apparatus for performing the method is also disclosed, including means for rotatably supporting the plate with its periphery exposed, drive means for rotating the supported plate, means for orienting a reinforcing wire in a position generally tangent to the supported plate, and means for heating the wire to a malleable state before winding about the plate.
Patent CA-1273214-C (CA)
Title: Electrically actuated lock mechanism
Inventor: QUANTZ NORMAN GEORGE
IPC: E05B81/14
Filed: 1986-11-13
Granted: 1990-08-28
Abstract: ABSTRACT OF THE DISCLOSURE An electrically actuated rear deck lock mechanism which may be locked or unlocked in a conventional manner. The lock mechanism latches the deck lid by engaging a lock bar after closure of the deck lid and through the use of a cam entrapping the lock bar to move it to a locked position. Once in the locked position, the electrical locking mechanism is free of all mechanical forces applied to the latch member such that any forces experienced during normal operation of the vehicle are observed through the mechanical inner lock of the latch with the lock bar without undue effect on the electrical components of the latch. The lock mechanism can also be moved to a locking position without interfering with the electrical locking portion of the mechanism and may be manually unlocked in the event of an electrical power failure.
Patent CA-1283119-C (CA)
Title: Hydroxyacetic acid derivatives for the treatment of diabetic complications
Inventor: LIPINSKI CHRISTOPHER A
IPC: C07D311/32
Filed: 1987-01-15
Granted: 1991-04-16
Abstract: ABSTRACT OF THE DISCLOSURE          Racemic and chiral (2R,4R)-4-c-hydroxy-2-r-(substituted) chroman (and thiochroman)-4-acetic acids of the formual:                               (wherein.          Z is O, S, SO or SO2;          R1 is alkyl, CF3 or (SH2)nAR [where n is 0-2, AR is optionally substituted phenyl] and R1 is H, methyl or ethyl, or R1 and R2 together (CH2)m [where m is 4 or 5], R3 is H or methyl, provided that R2 and R3 are each H when either Z is other than -O- or R1 is other than methyl, ethyl or CF3;         X is H, F, Cl, Br, emthyl, NO2, CN, CH2SO2 or benzoyl;         X1 is H, F, Cl, Br, CO2H, alkyl, alkoxy or benzyloxy;         X2 is H, F, Cl, Br or alkyl, or X1 and X2 are together 7,8-benzo) and their pharmaceutically acceptable salts, their use in the treatment of diabetic complications and intermediates therefor.
Patent CA-1283569-C (CA)
Inventor: KAKII TOSHIAKI
IPC: G02B6/38
Filed: 1987-03-13
Granted: 1991-04-30
Abstract: ABSTRACT OF THE DISCLOSURE An optical connector and splicer   including an optical fiber positioning member for optical coupling of optical fibers where the coupling is assisted by at least two guide pins.   The  optical  fiber  positioning member comprises  a  substrate  plate  and  a  flat  plate.    The substrate plate has optical fiber grooves and guide pin grooves each formed at one surface thereof for positioning the one optical fibers and said guide pins, respectively. The flat plate has a flat surface confronting with the grooved surface of the substrate plate.   An exposed area is formed on a part of the substrate plate where said flat plate is not joined for facilitating an insertion of the optical fibers into the optical fiber grooves. A method of the optical connector and splicer comprises the steps of:  preparing a substrate plate assembly form a single wafer made of a hard and brittle material;  continuously forming a predetermined pattern of optical fiber grooves and guide pin grooves on a surface of said substrate plate assembly; bonding at least one flat plate to said surface of said substrate plate assembly with an adhesive thin layer, so that optical fiber groove holes and guide pin groove holes are provided; cutting a bonded assembly into sections  each  having  predetermined  dimensions  of  said positioning member; and fixing the optical fibers in said optical fiber groove holes by bonding with an adhesive.
Patent CA-1275499-C (CA)
Title: Exposure control apparatus for a still video camera having an electronic viewfinder
Inventor: NUTTING THOMAS C
IPC: H04N5/235
Filed: 1987-06-09
Granted: 1990-10-23
Abstract: EXPOSURE CONTROL APPARATUS FOR A STILL VIDEO     CAMERA HAVING AN ELECTRONIC VIEWFINDER                        ABSTRACT A still video camera includes an electronic image sensor (12) as a signal source either for an electronic viewfinder (40) or for a still image processed by the camera and recorded upon a magnetic disk (48).  Since the viewfinder (40) operates in a movie mode (with a fixed exposure time), the light intensity required for a viewfinder display ordinarily differs from that required for a still exposure.  By commonly determining the correct exposure conditions for both the viewfinder display and the still exposure, time can be saved in shifting from the movie mode to the still mode. A sample of image light in the movie mode is diverted to a microprocessor-controlled exposure circuit (32), which integrates the light to determine the correct diaphragm aperture for both modes of operation.  The movie aperture is directly input to a diaphram driver (28) while the still aperture is saved in still registers (57)  until a still exposure is initiated by actuation of a still shutter release (80).
Patent CA-1290019-C (CA)
Inventor: KUWAHARA HIDEO
IPC: H04B10/63
Filed: 1987-06-15
Granted: 1991-10-01
Abstract: DUAL BALANCED OPTICAL SIGNAL RECEIVER              ABSTRACT OF THE DISCLOSURE      An optical signal receiver comprising an optical mixing/polarization splitting unit for producing IF optical signals having two orthogonally polarized components, an optical signal receiving unit for producing four corresponding IF electric signals, and a combining circuit for combining two IF electric signals having one polarization with the other two IF electric signals having the other polarization, suppressing fluctuation of the polarization and the intensity noise of the related local optical signal.  The intensity noise suppression is also effective for IF electric signals having a higher frequency range.
Patent CA-1282482-C (CA)
Title: Data packet switching system
Inventor: COATRIEUX JEAN-YVON
IPC: H04L12/56
Filed: 1987-06-26
Granted: 1991-04-02
Abstract: ABSTRACT             The system comprises input modules (Pei) receiving entering packets, output modules (PSi) transmitting outgoing packets, a control memory (M) with double access and divided into routing modules (PTi, PAj), and a resource control module (GR).  It also comprises an input time-division bus (BHDE) to connect timewise input modules (PEi) to routing modules (PTi, PAj) selected in the central memory (M) and an output time-division bus (BHDS) to connect timewise routing modules (PTi, PAj) of the central memory (M) to output modules (PSi).  The control module (GR) is bidirectionally connected to the input modules (PEi) and to the central memory (M) through the input time-division bus (BHDE), on one hand, and to the output modules (PSi) and the central memory (M) by the output time-division bus (BHDS), on the other hand.
Patent CA-1276377-C (CA)
Inventor: SASAKI YUKIHIKO
IPC: C09J7/20
Filed: 1987-07-06
Granted: 1990-11-13
Abstract: CURABLE ACRYLIC/FUMARIC PRESSURE-SENSITIVE ADHESIVES  Abstract of the Disclosure There is provided a curable pressure-sensitive-adhesive layer comprising an interpolymerized hard-monomer system including one alkyl methacrylate present in an amount up to about 25% by weight, based on the total weight of the monomers, and a soft-monomer system present in an amount of from about 50% to about 95% by weight, and comprising at least one alkyl monoester or diester of an unsaturated dicarboxylic acid containing 4 carbon atoms wherein each alkyl group independently contains from 4 to about 8 carbon atoms, the monoester or diester being present in a total amount of up to about 30% by weight, based on the total weight of the monomers, and at least one alkyl acrylate. Cure occurs by electron-beam radiation or by ultraviolet radiation, the former at a dosage of up to 200 kiloGrav, after application to a substrate.  A multifunctional monomer may be used to enhance radiant-energy cure.  The invention allows the use of diesters of unsaturated dicarboxylic acids, for example, dibutyl fumarate, in combination with energy curing, to enhance adhesive properties, an ability not shown by the prior art.
Patent CA-1300581-C (CA)
Title: Fiber optic lens and lamp assembly and method for installing same under floor covering and the like
Inventor: GRISE FREDERICK G J
IPC: F21V8/00
Filed: 1987-09-25
Granted: 1992-05-12
Abstract: ABSTRACT This invention discloses a fiber optic lens holder and lamp assembly for use in lighting systems used beneath carpets and other types of floor or wall coverings.  The lens assembly includes a housing having a cavity for receiving the lamp, an optically transparent web portion adjacent to the lamp cavity, and an annular end portion for receiving a bundle of optical fibers.  The optical fibers are fused together at one end and are secured in the housing at the other within the annular section.  The lens and lamp assembly is installed, typically with a flat cable conductor assembly, on the floor prior to laying of the carpet.  Holes are cut in the carpet corresponding with the locations for the fiber optic bundles.  The fiber optic bundles are passed through these holes as the carpet is laid down.  After the carpet is laid down, the fused end of each bundle is cut off, freeing the fiber ends from fusion with each other so that the fiber ends are flush with the surface of the carpet. Thus, the invention provides an unobtrusive and durable means for providing emergency or decorative floor illumination.
Patent CA-1320439-C (CA)
Title: Method and an apparatus for preparing tissue repair promoting substances
Inventor: WEIS-FOGH ULLA S
IPC: A61K35/16
Filed: 1987-10-05
Granted: 1993-07-20
Abstract: A METHOD AND AN APPARATUS FOR PREPARING TISSUE REPAIR PROMOTING          SUBSTANCES     ABSTRACT   A method for isolating tissue repair promoting substances from human or animal blood, which method comprises collecting the human or animal blood from a single human or animal individual in a first container of a container system comprising at least first and second interconnected containers; centrifuging the container system containing said blood so as to separate the blood in various fractions including a plasma fraction; transferring at least part of the plasma fraction to said second container of the con-tainer system; subjecting the plasma fraction in said second container to a low tem-perature so as to obtain a precipitate comprising tissue repair promoting substances; concentrating said precipitate in said second container so as to obtain a first fraction comprising a major part of the non-precipitated material, and a second fraction com-prising at least the major part of the precipitate and a minor part of the non-precipitated material; and separating said second fraction comprising the tissue repair promoting substances from said first fraction within the second container; and optionally heating said second fraction within one of the containers of the container system so as to dissolve the isolated precipitated tissue repair promoting substances.   Furthermore, fractions comprising tissue repair promoting substances derived from blood cells may be isolated within the container system, said fractions optionally being combined with the second fraction comprising tissue repair promoting substances derived from blood plasma.   At least part of the fractions obtained may be kept for application to a tissue of the human or animal individual from whom the blood was collected.